- Brand NameEmgality
- FormInjection
- Packing:Box
- Form :Injection
- Supply TypeExporter, Supplier, Retailer, Distributor, Importer, Trader
- Preferred Buyer Location All over the world
Galcanezumab, sold as Emgality, is a monoclonal antibody that blocks calcitonin gene-related peptide (CGRP), a substance involved in migraine and cluster headache. It is approved for preventive treatment of migraine and episodic cluster headache in the US and the EU.
Member Since 1 Year
Nature of Business Manufacturer
GST No. 24ABEFR7424A1ZL
For Buyer 
For Seller 
Help 
Rajkot, Gujarat